Abstract: Sucrose esters (SE) are surfactants with potential pharmaceutical applications because of their low toxicity, biocompatibility, and excellent biodegradability. Biodegradable and biocompatible copolymeric hydrogels based on glucose-6-acrylate-1, 2, 3, 4-tetraacetate (GATA) and methacrylic acid (MAA) were designed and synthesized. Because of the growing importance of sugar-based hydrogels as drug delivery systems, these new pH-responsive glucose-containing copolymeric hydrogels were investigated for oral drug delivery. The GATA monomer was synthesized and characterized. The copolymeric hydrogel was synthesized by free-radical polymerization. Azobisisobutyronitrile (AIBN) was the free-radical initiator employed and Cubane-1, 4-dicarboxylic acid (CDA) linked to two 2-hydroxyethyl methacrylate (HEMA) group was the crosslinking agent (CA) used for hydrogel preparations. The hydrogels were characterized by differential scanning calorimetry and FT-IR. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). A model drug, olsalazine [3, 3َ -azobis (6-hydroxy benzoic acid)] (OSZ) an azo derivative of 5-aminosalicylic acid (5-ASA), was entrapped in these gels and the in vitro release profiles were established separately in both enzyme-free SGF and SIF. The drug release was found to be faster in SIF. The drug-release profiles indicated that amount of drug release depends on their degree of swelling and crosslinking.
Introduction
Recent years have witnessed significant advances in controlled drug delivery using polymeric materials. Polymeric hydrogels are gaining more attention as drug delivery systems, especially for the controlled release of pharmaceutically active peptides and proteins [1, 2] . Hydrogels have been widely used in many biomedical applications including contact lenses, wound dressings, artificial organs and delivery carriers for bioactive agents because of their high degree of biocompatibility [3, 4] . High water content and low interfacial tensions with the surrounding biological environment impart biocompatibility to the hydrogels [5] . Stimuli responsive polymers have the possibility to achieve a specific drug release in response to internal or external stimuli [6] . Stimuli such as changes in pH, temperature and glucose concentrations help stimuliresponsive polymers to achieve a desired function [7] . Although oral delivery has become a widely accepted route of administration of therapeutic drugs, the gastrointestinal tract presents several formidable barriers against drug delivery. Colonic drug delivery has gained increased importance not just for the delivery of the drugs for the treatment of local diseases associated with the colon but also for its potential for the delivery of proteins and therapeutic peptides. To achieve successful colonic delivery, a drug needs to be protected from absorption in the environment of the upper gastrointestinal tract (GIT) and then be abruptly released into the proximal colon, which is considered the optimum site for colon-targeted delivery of drugs. Targeting of colon is naturally of value for the topical treatment of diseases of colon such as Chron's diseases, ulcerative colitis, colorectal cancer and amebiasis. The various strategies for targeting orally administered drugs to the colon include covalent linkage of a drug with a carrier, coating with pH-sensitive polymers, formulation of time released systems, exploitation of carriers that are degraded specifically by colonic bacteria, bioadhesive systems and osmotic controlled drug delivery systems [8, 9] . Biologically, adhesive delivery systems offer important advantages [10, 11] . The bioadhesion is defined as the ability of a material to adhere to a biological tissue for an extended period of time. Bioadhesive potential of polymers is sufficient to make it suitable for prolonged contact with the intestinal epithelium for extended periods of time and actually penetrate it through and between the cells. Hydrophilic polymers and hydrogels containing carboxyl groups have displayed bioadhesive properties [12, 13] . pH-sensitive hydrogels are not only bioadhesive, but also swell in response to a pH change. These polymers are able to protect drugs from the acidic pH of the stomach, and release it in the more basic pH of the intestine. These materials also appear to temporarily open connections between intestinal cells, allowing the drugs to pass through. Synthetic polymers containing side-chain carbohydrates are considered as high value polymeric materials because of their potential as biocompatible materials with medical applications. These applications are generally based on the fact that cell-cell interactions between oligosaccharides and lipids play an important role in various life processes [14] . For example, Kobayashi et al. have reported the synthesis of polystyrene having pendent lactose residues and its application as substratum for culture of liver cells [15] . Considering the potential advantages offered by sugar-based polymeric systems, we initiated the design and synthesis of new glucose-containing biocompatible and biodegradable polymeric hydrogels for drug delivery tissue engineering applications. The glucose-6-acrylate-1, 2, 3, 4-tetraacetate (GATA) monomer was synthesized by modification of a synthetic route reported earlier [16] . In this article, we report the synthesis and hydrolytic behavior of glycopolymer hydrogels containing [3, 3َ -azobis (6-hydroxy benzoic acid)] as azo derivatives of 5-aminosalicylic acid (5-ASA). 5-aminosalicylic acid (5-ASA) is useful for localized chemotherapy of inflammatory bowl disease (IBD), but this drug is likely to be absorbed or degraded in the stomach and small intestine before reaching the colon sites. The colon is known to be a reductive medium in which azo groups can be cleaved with formation of the corresponding amines. The metabolic reduction of azo compounds is considered as an important detoxification route [17] . Various prodrugs (sulfasalazine, ipsalazine, balsalazine and olsalazine) have been developed that are aimed to deliver 5-amino salicylic acid (5-ASA) for localized chemotherapy of IBD [18] . The most interesting prodrug is olsalazine (OSZ), which is a dimer representing two molecules of 5-ASA that are linked via an azo bond. When olsalazine reaches the large intestine, it is cleaved releasing two moles of 5-ASA for every mole of olsalazine administered. The methacryloyloxyethyl esters of Cubane-1, 4-dicarboxylic acid (CDA) were prepared as a crosslinking agent (CA). Free radical cross-linking copolymerization of the resulting monomer (GATA) and methacrylic acid (MAA) in two different molar ratios, with various ratios of CA produced polymer network bonded drugs (PBDs). The equilibrium swelling studies were carried out in enzyme-free samples of SGF and SIF. OSZ was entrapped as the model drug and in vitro release profiles were established separately in enzyme-free simulated gastric and intestinal fluids SGF and SIF, respectively.
Experimental

Materials
Cubane-1, 4-Bis (methacryloyloxyethyl) carboxylate (CA) was prepared by the method described in the literature [19] . Triphenylcarbinol and methacrylic acid (MAA) were purchased from Merck Co. The solvents and reagents were obtained from Fluka. The IR spectra were recorded on a Shimadzu FT IR-408 spectrophotometer. The DSC curves were obtained on a TGA/SDTA 851 calorimeter at heating and cooling rates of 10º C/min under N 2 . The amount of released drug was determined on a Philips PU 8620 UV spectrophotometer at the absorption maximum of the free drug in aqueous alkali (λmax =245 nm) using a 1 cm quartz cell. Enzyme-free SGF (pH 1) or SIF (pH 7.4) were prepared according to the method described in the US Pharmacopoeia [20] . The HPLC apparatus (Bischoff, Germany) consisted of Bruker LC-21, equipped with a Bruker UV-Vis detector model LC 313 I, Rheodyne loop injector and a C18 reversephase column of Spherisorb-CN (250 × 4.6 mm id., particle size 5 µm).
Synthesis of triphenylchloromethane: (TPhCM)
A mixture of 250 g of pure triphenylcarbinol and 80 mL of dry benzene was placed in a 1 liter round-bottomed flask provided with a reflux condenser. The condenser was provided with a calcium chloride tube at the top. The mixture was heated on a steam bath, when it becomes hot; 50 mL of acetyl chloride is added through the top of the condenser. Heating was continued while the mixture is shaken vigorously. In about 5 minutes all the solid triphenylcarbinol disappeared resulting in a clear solution. In the course of 10 minutes, an additional 100 mL of acetyl chloride was added in 10 mL portions. The solution was then refluxed for 30 minutes longer. The solution was cooled by shaking the flask under running water and during this operation 200 mL of petroleum ether was added through the top of the condenser, and the triphenylchloromethane separated in sugarlike crystals. The mixture was cooled in an ice bath for 1-2 hours, and the product filtered, washed with 150 mL of petroleum ether and dried in vacuum. The yield was 224 g (83%) and the TPhCM melts at 111° C.
Synthesis of 6-trityl-β-d-glucose-1, 2, 3, 4-tetraacetate: (TGTA)
A mixture containing 120 g (0.67 mol) of anhydrous glucose, 193.2 g (0.7 mol) of trityl chloride and 500 mL of anhydrous pyridine was heated on the steam cone until complete dissolution. Without cooling, 360 mL of acetic anhydride was added in one portion. The reaction mixture was poured slowly into 10 Liter of ice water, to which 500 mL of acetic acid has been added, after keeping for 12 hours. Vigorous mechanical stirring of the mixture for 2 hours resulted in white granular precipitate which was filtered, washed well with cold water and then air dried. The dried solid was digested with 500 mL of ether (the α-isomer is soluble in ether but the β-isomer is insoluble). The insoluble portion was dissolved in hot 95% ethanol (approximately 3 liter) and the solution was decolorized and filtered while it was still hot. The filtrate upon cooling, deposited fine needles of 6-trityl-β-d-glucose-1, 2, 3, 4-tetraacetate of sufficient purity for further use. The yield at this point was about 169 g (43%). Recrystallization from 95% ethanol gave the pure compound which melts at 166° C. The yield of purified material was 137 g (35% 
Synthesis of β-d-glucose-1, 2, 3, 4-tetraacetate: (GTA)
A solution of 46 g (0.078 mol) of 6-trityl-β-d-glucose-1, 2, 3, 4-tetraacetate in 200 mL of acetic acid was prepared by warming on the steam bath. The solution was then cooled to approximately 10° C. 18 mL of a saturated solution of dry hydrogen bromide in acetic acid was added, and the reaction mixture was shaken for about 45 seconds. The trityl bromide formed during the reaction was removed at once by filtration, and the filtrate poured immediately into 1 liter of cold water. The tetraacetate was extracted with 250 mL of chloroform. The chloroform extract was washed four times with ice water and dried over anhydrous sodium sulfate. The drying agent was removed and the chloroform was evaporated under reduced pressure at room temperature. The remaining syrup was covered with 100 mL of anhydrous ether and rubbed with a glass rod and crystallization occurred immediately. The product was removed and purified by dissolving it in the minimum amount of chloroform and adding anhydrous ether until crystallization started. The yield was 15 g (55%). The purified product melts at 128° C. 
Synthesis of glucose-6-acrylate-1, 2, 3, 4-tetraacetate: (GATA)
A mixture of 1.5 g (0.004 mol) GTA and 1.3 g triethylamine in 30 mL dried THF was added with stirring to a solution of 1.17 g (0.012 mol) acryloyl chloride in 10 mL THF under N 2 at -5º C. The stirring was continued at room temperature for 24 h. The precipitated was filtered, and the filtrate was poured into 50 mL of cold acetone to precipitate the GATA. The solid product was filtered, washed with cold acetone and dried in vacuum which afforded of GATA as a white solid (Scheme 1). IR (KBr): 2937, 1755, 1618, 1261, 1225 cm 
Scheme 1. Preparation of GATA.
Copolymerization: General Procedure
Specific mol percents of CA (5 and 10%) with mixture of two different molar ratios (1:3, 1:5) of GATA and methacrylic acid were polymerized at 60-70°C in a thermostatic water bath, using 2, 2′-azobisisobutyronitrile (AIBN) as initiator ([I] = 0.02 M), and dried dioxane as solvent ([M] = 1 M). All experiments were carried out in Pyrex glass ampoules sealed under vacuum. After the specific time (48 h), the precipitated network polymer was collected and dried in vacuum (scheme 2).
Scheme 2. Preparation of network's glycopolymers.
Drug loading in hydrogels
20 mg of each hydrogel was dispersed with stirring in 5 mL of solution containing 2 mg of OSZ to suck up the total amount of the drug solution. After approximately 60 min, the completely swollen hydrogels loaded with drug were placed in desiccators and dried under vacuum at room temperature.
Determination of amount of drug entrapped
The amount of drug entrapped in the hydrogels was determined by an indirect method. After gel preparation, the washings with methanol were collected and tested using UV-Vis spectroscopy. The difference between the amount of drug initially employed and the drug content in the washings was taken as an indication of the amount of drug entrapped. The values of quantification of entrapped drug in the hydrogel based on the total amount are given in Table1.
Tab. 1. DSC data and composition of copolymers.
Characterization of hydrolysis product
Polymer-drug adduct (90 mg) was dispersed in 20 mL of pH 8 buffered solution. The reaction mixture was maintained at 37º C. After 24 h the hydrolysis solution was sampled and neutralized with 1 M HCl and the solvent was evaporated in vacuum. The resulting crude product was treated with 10 mL of acetone and heated. The suspension was then filtered and the acetone solution was evaporated under reduced pressure. Samples were measured using HPLC-UV. The column used was ODS (C18) and isocratic elution was performed using 50% methanol and 50% buffer containing 0.05 M NH 3 . The flow-rate and injection volume were 1 mL/min and 100 µL, respectively. OSZ was detected at a retention time of 2.8 min.
In vitro release studies
The copolymers (50 mg) were poured into 3 mL of aqueous buffer solution (SGF: pH 1 or SIF: pH 7.4). The mixture was introduced into a cellophane membrane dialysis bag. The bag was closed and transferred to a flask containing 20 mL of the same solution maintained at 37° C. The external solution was continuously stirred, and 3 mL samples were removed at selected intervals. The volume removed was replaced with SGF or SIF. Triplicate samples were used. The sample of hydrolyzate was analyzed by UV spectrophotometer, and the quantity of OSZ as an azo derivative of 5-ASA was determined using a standard calibration curve obtained under the same conditions. 
Measurement of swelling ratio
The synthesized network polymers swell and become soft in solvents such as H 2 O and most organic solvents without dissolving. To measure the swelling, preweighed dry drug-free hydrogels were immersed in various buffer solutions (pH 7.4 and pH 1) at 37º C. After excess water on the surface was removed with the filter paper, the weight of the swollen samples was measured at various time intervals. The procedure was repeated until there was no further weight increase. The degree of swelling was calculated according the relation:
where, W s and W d represent the weight of swollen and dry samples, respectively. Time-dependent swelling behavior of cross-linked polymers in pH 1 and pH 7.4 at 37º C are plotted in Figure 1 . Drug delivery to the colon has implications in a number of therapeutic areas, particularly in the treatment of colonic diseases such as ulcerative colitis and Chron's disease and in the oral delivery of peptides and other drugs degraded in the upper gastrointestinal tracts. Ionic hydrogels, which could be cationic, containing basic functional groups or anionic, containing acidic functional groups, have been reported to be very sensitive to changes in the environmental pH. The swelling properties of the ionic hydrogels are unique due to the ionization of their pendent functional groups. Because hydrophilic polymers and hydrogels containing carboxylic groups have displayed bioadhesive properties, design and synthesis of new biodegradable and biocompatible polymeric hydrogel systems based on suger-containing monomers was the primary objective in our study. We were interested in the chemical modification of pH-sensitive hydrogel, especially by glycosidation reactions. Its success promises to attract much attention as a new type of synthetic polymer with pendent sugar residues for producing not only biodegradable but biomedically useful materials. These polymeric hydrogels containing hydrophilic constituents are expected to serve not only as drug delivery matrices for oral drug delivery but also as tissue engineering scaffolds. The bioadhesive character of both the sugar monomer and the methacrylic acid serve the purpose of prolonged attachment to the mucous membrane in the gastrointestinal (GI) tract for controlled drug delivery. As shown in figure 1 , an increase in the content of MAA in the feed monomer mixtures resulted in less swelling in SGF but greater swelling in SIF. This is because the increase of MAA content in the hydrogels provides more hydrogen bonds at low pH and more electrostatic repulsion at high pH. Based on this rationale, we have synthesized new hydrogels containing different molar ratios of acidic monomers. In the low pH range of the stomach, the gels have a low equilibrium degree of swelling and the drug is protected against digestion by enzymes. The degree of swelling increases as the hydrogel passes down the gastrointestinal tract due to increased pH. In colon, the gels have reached a high degree of swelling that makes the drug being released from the gel.
Results and Discussion
PBDs
Thermal Behavior
The thermal behavior of a polymer is important in relation to its properties for controlling the release rate in order to have a suitable drug dosage form. Differential scanning calorimetry (DSC) and Thermal gravimetry (TGA) for the network polymers were evaluated. The glass transition temperature (Tg) was determined from the DSC thermograms. The values are given in Table1. The higher Tg values probably related to the introduction of crosslinks, which would decrease the flexibility of the chains and the ability of the chains to undergo segmental motion, which would increase the Tg values [19] . On the other hand the introduction of a strongly polar carboxylic acid group can increase the Tg value because of the formation of internal hydrogen bonds between the polymer chains.
Drug Release by Hydrolysis of Polymer Bonded Drugs
In order to study potential application of PBDs containing azo derivatives of 5-aminosalicylic acid as a pharmaceutically active compound, we have studied the drug releases behavior of the polymers under physiological conditions. Although the polymers were not soluble in water, they were dispersed in a buffer solution, and the drug release was evaluated as a heterogeneous system. The percent of released drug from polymeric carriers as a function of time is shown in Figure 2 . The concentration of OSZ released at selected time intervals was determined by UV spectrophotometry at 245 nm. The order of release in this series was significantly affected by polymer composition. It appears that the degree of drug release from network polymers depends on the degree of swelling and reticulation. The increase in crosslinking density through addition of crosslinking agents are known to reduce the equilibrium swelling. Reduced swelling is often marked with reduced diffusion coefficient. On the other hand, a high different hydrolysis rate for polymers at pH 1 and 7.4 can be related to the number of carboxylic acid groups on monomeric units along the polymer chain. At low pH, polymers have a low equilibrium degree of swelling but these increases due to increased pH. At pH 7.4 with complete ionization and increased hydrophilicity of the polymer, swelling of polymer is increased and the drug release rate was increased [21] .
Conclusions
The oral administration of drugs is the most attractive route. However reduced gastrointestinal side effects and degradation of drugs makes the large intestine optimal for drug delivery due to the high residence time and low digestive enzymatic activity. The metabolic reduction of OSZ in colon equipped the anti-inflammatory agent 5-ASA for colon specific drug delivery. The swelling and hydrolytic behavior of the hydrogels was dependent on the content of MAA groups and caused a decrease in gel swelling in SGF or an increase in gel swelling in SIF [22] [23] [24] . Methacrylic-type polymeric prodrugs with different contents of MAA and CA were synthesized by free radical cross-linked copolymerization. By regulating the crosslinking percentage of the MAA copolymers, pH-sensitive hydrogels with improved optimal hydrolysis rates were obtained. The drug release of drug-polymer conjugates were carried out at pH 1 and pH 7.4 at 37° C. The drug-release profiles indicated that the drug entrapped in hydrogels is released faster in SIF than in SGF as a result of the pH sensitivity. These preliminary investigations also revealed that GATA hydrogels could be applied for the oral drug delivery by virtue of both the bioadhesive and pH-sensitive nature of the glucose-based polymeric systems. This study also envisaged the potential of these matrices for tissue engineering applications. Based on the great difference in hydrolysis rates at pH 1 and 7.4, these hydrogels appears to be good candidates for colon-specific drug delivery.
